Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4795-4803

  Jiang, Shaoning ^a   Park, Dae Won ^a,b   Tadie, Jean Marc ^a,c   Gregoire, Murielle ^d   Deshane, Jessy ^a   Pittet, Jean Francois ^e   Abraham, Edward ^f   Zmijewski, Jaroslaw W ^a  

^a and Clinical Center   (United States)

^b Korea University College of Medicine   (South Korea)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HISTONE H3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION AND CHARACTERISTICS; LUNG EDEMA; MOUSE; NEUTROPHIL EXTRACELLULAR TRAP FORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ACUTE LUNG INJURY; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CHEMOKINE CXCL2; DISEASE MODELS, ANIMAL; FEMALE; HISTONES; HMGB1 PROTEIN; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; NEUTROPHIL ACTIVATION; NEUTROPHILS; RESISTIN; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901271982     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302764     Document Type: Article

References (72)

1. Schwartz, D. R., and M. A. Lazar. 2011. Human resistin: found in translation from mouse to man. Trends Endocrinol. Metab. 22: 259-265.
2. Lazar, M. A. 2007. Resistin- and Obesity-associated metabolic diseases. Horm. Metab. Res. 39: 710-716.
3. Steppan, C. M., and M. A. Lazar. 2004. The current biology of resistin. J. Intern. Med. 255: 439-447.
4. Kusminski, C. M., P. G. McTernan, and S. Kumar. 2005. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. 109: 243-256.
5. Qatanani, M., N. R. Szwergold, D. R. Greaves, R. S. Ahima, and M. A. Lazar. 2009. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J. Clin. Invest. 119: 531-539.
6. Muse, E. D., S. Obici, S. Bhanot, B. P. Monia, R. A. McKay, M. W. Rajala, P. E. Scherer, and L. Rossetti. 2004. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114: 232-239.
7. Kang, S., E. R. Chemaly, R. J. Hajjar, and D. Lebeche. 2011. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J. Biol. Chem. 286: 18465-18473.
8. Hardie, D. G., F. A. Ross, and S. A. Hawley. 2012. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13: 251-262.
9. Hardie, D. G., and K. Sakamoto. 2006. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21: 48-60.
10. McVay, L. D., S. A. Keilbaugh, T. M. Wong, S. Kierstein, M. E. Shin, M. Lehrke, M. I. Lefterova, D. E. Shifflett, S. L. Barnes, F. Cominelli, et al. 2006. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J. Clin. Invest. 116: 2914-2923.
11. Munitz, A., A. Waddell, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg. 2008. Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J. Allergy Clin. Immunol. 122: 1200-1207.e1.
12. Osborne, L. C., K. L. Joyce, T. Alenghat, G. F. Sonnenberg, P. R. Giacomin, Y. Du, K. S. Bergstrom, B. A. Vallance, and M. G. Nair. 2013. Resistin-like molecule a promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation. J. Immunol. 190: 2292-2300.
13. Pang, S. S., and Y. Y. Le. 2006. Role of resistin in inflammation and inflammation-related diseases. Cell. Mol. Immunol. 3: 29-34.
14. Patel, L., A. C. Buckels, I. J. Kinghorn, P. R. Murdock, J. D. Holbrook, C. Plumpton, C. H. Macphee, and S. A. Smith. 2003. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 300: 472-476.
15. Bokarewa, M., I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski. 2005. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174: 5789-5795.
16. Sundén-Cullberg, J., T. Nyströlm, M. L. Lee, G. E. Mullins, L. Tokics, J. Andersson, A. Norrby-Teglund, and C. J. Treutiger. 2007. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit. Care Med. 35: 1536-1542.
17. Koch, A., O. A. Gressner, E. Sanson, F. Tacke, and C. Trautwein. 2009. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit. Care 13: R95.
18. Silswal, N., A. K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, and N. Z. Ehtesham. 2005. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334: 1092-1101.
19. Beier, J. I., L. Guo, C. von Montfort, J. P. Kaiser, S. Joshi-Barve, and G. E. Arteel. 2008. New role of resistin in lipopolysaccharide-induced liver damage in mice. J. Pharmacol. Exp. Ther. 325: 801-808.
20. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
21. Grommes, J., and O. Soehnlein. 2011. Contribution of neutrophils to acute lung injury. Mol. Med. 17: 293-307.
22. Caudrillier, A., K. Kessenbrock, B. M. Gilliss, J. X. Nguyen, M. B. Marques, M. Monestier, P. Toy, Z. Werb, and M. R. Looney. 2012. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122: 2661-2671.
23. Tadie, J. M., H. B. Bae, S. Jiang, D. W. Park, C. P. Bell, H. Yang, J. F. Pittet, K. Tracey, V. J. Thannickal, E. Abraham, and J. W. Zmijewski. 2013. HMGB1 promotes neutrophil extracellular trap formation through interactions with Tolllike receptor 4. Am. J. Physiol. Lung Cell. Mol. Physiol. 304: L342-L349.
24. Zawrotniak, M., and M. Rapala-Kozik. 2013. Neutrophil extracellular traps (NETs) - formation and implications. Acta Biochim. Pol. 60: 277-284.
25. Villanueva, E., S. Yalavarthi, C. C. Berthier, J. B. Hodgin, R. Khandpur, A. M. Lin, C. J. Rubin, W. Zhao, S. H. Olsen, M. Klinker, et al. 2011. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187: 538-552.
26. Abraham, E. 2003. Neutrophils and acute lung injury. Crit. Care Med. 31(4, Suppl.) S195-S199.
27. Zhao, X., J. W. Zmijewski, E. Lorne, G. Liu, Y. J. Park, Y. Tsuruta, and E. Abraham. 2008. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L497-L504.
28. Jiang, S., D. W. Park, W. S. Stigler, J. Creighton, S. Ravi, V. Darley-Usmar, and J. W. Zmijewski. 2013. Mitochondria and AMP-activated protein kinasedependent mechanism of efferocytosis. J. Biol. Chem. 288: 26013-26026.
29. O'Neill, L. A., and D. G. Hardie. 2013. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493: 346-355.
30. Long, Y. C., and J. R. Zierath. 2006. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116: 1776-1783.
31. Hardie, D. G. 2007. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 47: 185-210.
32. Sag, D., D. Carling, R. D. Stout, and J. Suttles. 2008. Adenosine 59- monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181: 8633-8641.
33. Bae, H. B., J. W. Zmijewski, J. S. Deshane, J. M. Tadie, D. D. Chaplin, S. Takashima, and E. Abraham. 2011. AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils. FASEB J. 25: 4358-4368.
34. Tadie, J. M., H. B. Bae, J. S. Deshane, C. P. Bell, E. R. Lazarowski, D. D. Chaplin, V. J. Thannickal, E. Abraham, and J. W. Zmijewski. 2012. Tolllike receptor 4 engagement inhibits adenosine 59-monophosphate-activated protein kinase activation through a high mobility group box 1 proteindependent mechanism. Mol. Med. 18: 659-668.
35. Luo, Z., Y. Zhang, F. Li, J. He, H. Ding, L. Yan, and H. Cheng. 2009. Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells. Endocrine 36: 60-69.
36. Ou, H. C., W. J. Lee, C. M. Wu, J. F. Chen, and W. H. Sheu. 2012. Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling. J. Vasc. Surg. 55: 1104-1115.
37. Ranieri, V. M., G. D. Rubenfeld, B. T. Thompson, N. D. Ferguson, E. Caldwell, E. Fan, L. Camporota, and A. S. Slutsky; ARDS Definition Task Force. 2012. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307: 2526-2533.
38. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay; International Sepsis Definitions Conference. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 29: 530-538.
39. Tadié, J. M., H. B. Bae, S. Banerjee, J. W. Zmijewski, and E. Abraham. 2012. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing. Am. J. Physiol. Cell Physiol. 302: C249-C256.
40. Zmijewski, J. W., E. Lorne, S. Banerjee, and E. Abraham. 2009. Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L624-L634.
41. Zmijewski, J. W., X. Zhao, Z. Xu, and E. Abraham. 2007. Exposure to hydrogen peroxide diminishes NF-kappaB activation, IkappaB-alpha degradation, and proteasome activity in neutrophils. Am. J. Physiol. Cell Physiol. 293: C255-C266.
42. Zmijewski, J. W., S. Banerjee, H. Bae, A. Friggeri, E. R. Lazarowski, and E. Abraham. 2010. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 285: 33154-33164.
43. Zmijewski, J. W., S. Banerjee, and E. Abraham. 2009. S-glutathionylation of the Rpn2 regulatory subunit inhibits 26 S proteasomal function. J. Biol. Chem. 284: 22213-22221.
44. Foster, W. M., D. M. Walters, M. Longphre, K. Macri, and L. M. Miller. 2001. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J. Appl. Physiol. 90: 1111-1117.
45. Zmijewski, J. W., E. Lorne, X. Zhao, Y. Tsuruta, Y. Sha, G. Liu, G. P. Siegal, and E. Abraham. 2008. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am. J. Respir. Crit. Care Med. 178: 168-179.
46. Brass, D. M., J. W. Hollingsworth, E. McElvania-Tekippe, S. Garantziotis, I. Hossain, and D. A. Schwartz. 2007. CD14 is an essential mediator of LPSinduced airway disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L77-L83.
47. Zmijewski, J. W., E. Lorne, X. Zhao, Y. Tsuruta, Y. Sha, G. Liu, and E. Abraham. 2009. Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am. J. Respir. Crit. Care Med. 179: 694-704.
48. Park, H. K., M. Qatanani, E. R. Briggs, R. S. Ahima, and M. A. Lazar. 2011. Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice. Diabetes 60: 775-783.
49. Johansson, L., A. Linnér, J. Sundén-Cullberg, A. Haggar, H. Herwald, K. Loré, C. J. Treutiger, and A. Norrby-Teglund. 2009. Neutrophil-derived hyperresistinemia in severe acute streptococcal infections. J. Immunol. 183: 4047-4054.
50. Xu, J., X. Zhang, R. Pelayo, M. Monestier, C. T. Ammollo, F. Semeraro, F. B. Taylor, N. L. Esmon, F. Lupu, and C. T. Esmon. 2009. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15: 1318-1321.
51. Clark, S. R., A. C. Ma, S. A. Tavener, B. McDonald, Z. Goodarzi, M. M. Kelly, K. D. Patel, S. Chakrabarti, E. McAvoy, G. D. Sinclair, et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13: 463-469.
52. Remijsen, Q., T. W. Kuijpers, E. Wirawan, S. Lippens, P. Vandenabeele, and T. Vanden Berghe. 2011. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 18: 581-588.
53. Yipp, B. G., B. Petri, D. Salina, C. N. Jenne, B. N. Scott, L. D. Zbytnuik, K. Pittman, M. Asaduzzaman, K. Wu, H. C. Meijndert, et al. 2012. Infectioninduced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18: 1386-1393.
54. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241.
55. Xing, J., Q. Wang, K. Coughlan, B. Viollet, C. Moriasi, and M. H. Zou. 2013. Inhibition of AMP-activated protein kinase accentuates lipopolysaccharideinduced lung endothelial barrier dysfunction and lung injury in vivo. Am. J. Pathol. 182: 1021-1030.
56. Rittirsch, D., M. A. Flierl, D. E. Day, B. A. Nadeau, F. S. Zetoune, J. V. Sarma, C. M. Werner, G. A. Wanner, H. P. Simmen, M. S. Huber-Lang, and P. A. Ward. 2009. Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways. PLoS Pathog. 5: e1000464.
57. Lorne, E., X. Zhao, J. W. Zmijewski, G. Liu, Y. J. Park, Y. Tsuruta, and E. Abraham. 2009. Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am. J. Respir. Cell. Mol. Biol. 41: 237-245.
58. Strassheim, D., K. Asehnoune, J. S. Park, J. Y. Kim, Q. He, D. Richter, K. Kuhn, S. Mitra, and E. Abraham. 2004. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J. Immunol. 172: 5727-5733.
59. Wang, X. Q., K. Bdeir, S. Yarovoi, D. B. Cines, W. Fang, and E. Abraham. 2006. Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. J. Immunol. 177: 5550-5557.
60. Benomar, Y., A. Gertler, P. De Lacy, D. Crépin, H. Ould Hamouda, L. Riffault, and M. Taouis. 2013. Central resistin overexposure induces insulin resistance through Toll-like receptor 4. Diabetes 62: 102-114.
61. Meares, G. P., H. Qin, Y. Liu, A. T. Holdbrooks, and E. N. Benveniste. 2013. AMP-activated protein kinase restricts IFN-g signaling. J. Immunol. 190: 372-380.
62. Dong, Y., M. Zhang, S. Wang, B. Liang, Z. Zhao, C. Liu, M. Wu, H. C. Choi, T. J. Lyons, and M. H. Zou. 2010. Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 59: 1386-1396.
63. Tsaknis, G., I. I. Siempos, P. Kopterides, N. A. Maniatis, C. Magkou, M. Kardara, S. Panoutsou, A. Kotanidou, C. Roussos, and A. Armaganidis. 2012. Metformin attenuates ventilator-induced lung injury. Crit. Care 16: R134.
64. Park, C. S., B. R. Bang, H. S. Kwon, K. A. Moon, T. B. Kim, K. Y. Lee, H. B. Moon, and Y. S. Cho. 2012. Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem. Pharmacol. 84: 1660-1670.
65. Deng, Y., Z. Yang, Y. Gao, H. Xu, B. Zheng, M. Jiang, J. Xu, Z. He, and X. Wang. 2013. Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PLoS ONE 8: e64375.
66. Sha, Y., J. Zmijewski, Z. Xu, and E. Abraham. 2008. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180: 2531-2537.
67. Wang, Y., M. Li, S. Stadler, S. Correll, P. Li, D. Wang, R. Hayama, L. Leonelli, H. Han, S. A. Grigoryev, et al. 2009. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184: 205-213.
68. Parker, H., M. Dragunow, M. B. Hampton, A. J. Kettle, and C. C. Winterbourn. 2012. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J. Leukoc. Biol. 92: 841-849.
69. Alba, G., R. El Bekay, M. Alvarez-Maqueda, P. Chacón, A. Vega, J. Monteseirín, C. Santa María, E. Pintado, F. J. Bedoya, R. Bartrons, and F. Sobrino. 2004. Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. FEBS Lett. 573: 219-225.
70. Rubenfeld, G. D., E. Caldwell, E. Peabody, J. Weaver, D. P. Martin, M. Neff, E. J. Stern, and L. D. Hudson. 2005. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-1693.
71. Sevransky, J. E., G. S. Martin, C. Shanholtz, P. A. Mendez-Tellez, P. Pronovost, R. Brower, and D. M. Needham. 2009. Mortality in sepsis versus non-sepsis induced acute lung injury. Crit. Care 13: R150.
72. Pirvulescu, M., I. Manduteanu, A. M. Gan, D. Stan, V. Simion, E. Butoi, M. Calin, and M. Simionescu. 2012. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation. Biochem. Biophys. Res. Commun. 422: 321-326.